[Form 4] Stitch Fix, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Anthony Bacos, Stitch Fix (SFIX) Chief Product/Technology Officer, reported option exercise and open-market sales executed under a Rule 10b5-1 plan. He exercised an employee stock option to acquire 60,000 Class A shares at an exercise price of $3.99 on 09/19/2025, increasing exercisable option holdings by 60,000 shares. On the same date he sold a total of 90,000 Class A shares in multiple transactions: 60,000 sold at a weighted average price of $5.6135 and 30,000 sold at a weighted average price of $5.6141, with the underlying sale prices ranging from $5.545 to $5.695 per share. Following these transactions he beneficially owns 602,543 Class A shares.

Positive

• 60,000 option shares were exercised at a $3.99 exercise price, increasing exercisable holdings
• Sales and exercise were executed under a Rule 10b5-1 plan, providing a pre-established framework for timing and limiting ad hoc trading concerns

Negative

• 90,000 Class A shares were sold on 09/19/2025, reducing immediate beneficial ownership (sales at weighted averages of $5.6135 and $5.6141)
• Reported sale prices span a range ($5.545 to $5.695), indicating multiple transactions rather than a single block sale

Insights

Securities Analyst

TL;DR: Insider exercised options and sold shares under a Rule 10b5-1 plan; net beneficial ownership remains materially disclosed.

The filing shows an option exercise for 60,000 shares at $3.99 and contemporaneous sales of 90,000 shares executed under a 10b5-1 plan, with reported sale prices between $5.545 and $5.695 per share. These are routine inside liquidity transactions rather than corporate disclosures affecting fundamentals. The report includes precise quantities and weighted-average sale prices and confirms the transactions were governed by a pre-established trading plan, which limits timing-based interpretation.

Corporate Governance Expert

TL;DR: Transactions were executed under a Rule 10b5-1 plan, indicating preplanned insider activity and compliance with disclosure rules.

The Form 4 documents compliance with Section 16 reporting and cites a March 13, 2025 Rule 10b5-1 plan for both the option exercise and sales. The filing specifies vesting schedule details for the option and provides the weighted-average sale price range, which is helpful for transparency. No amendments or regulatory exceptions are noted; the signature is by an attorney-in-fact, which is standard practice.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bacos Anthony

(Last) (First) (Middle)

1 MONTGOMERY STREET

(Street)

SAN FRANCISCO CA 94104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stitch Fix, Inc. [ SFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Prod/Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/19/2025		M(1)		60,000	A	$3.99	889,966	D
Class A Common Stock	09/19/2025		S(1)		60,000	D	$5.6135(2)	829,966	D
Class A Common Stock	09/19/2025		S(1)		30,000	D	$5.6141(2)	799,966	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$3.99	09/19/2025		M(3)			60,000	(4)	12/07/2033	Class A Common Stock	60,000	$0	602,543	D

Explanation of Responses:

1. Shares were disposed of pursuant to a Rule 10b5-1 plan entered into on March 13, 2025.

2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $5.545 to $5.695 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Options were exercised pursuant to a Rule 10b5-1 plan entered into on March 13, 2025.

4. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

	/s/ Casey O'Connor, Attorney-in-Fact for Anthony Bacos	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Anthony Bacos report on Form 4 for SFIX?

He reported exercising an employee stock option to acquire 60,000 Class A shares at $3.99 and selling a total of 90,000 Class A shares on 09/19/2025.

Were the sales executed under a trading plan?

Yes. The filing states the sales and option exercise were pursuant to a Rule 10b5-1 plan entered into on March 13, 2025.

At what prices were the shares sold?

The reported weighted-average sale prices were $5.6135 for 60,000 shares and $5.6141 for 30,000 shares, with individual sale prices ranging from $5.545 to $5.695.

How many Class A shares does Anthony Bacos beneficially own after these transactions?

The filing reports 602,543 Class A shares beneficially owned following the reported transactions.

Is there vesting information for the exercised option?

Yes. The filing notes that 25% vested on June 12, 2024, with the remaining shares vesting in specified quarterly installments described in the Form 4.